Cytokinetics (CYTK) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
License revenues from related parties: 53.03M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $11.24 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
